Clinical-stage biotechnology company Vaxxas has announced the publication of data supporting the potential use of its high-density microarray patch technology to deliver nucleic acid-based vaccines in collaboration with The University of Queensland and Technovalia, an Australian vaccine developer. …
New data supports effective delivery of DNA-based vaccines using patch
March 5, 2025 Australian Biotech
Latest Video
New Stories
-
Government partners with Baxter to increase local production of IV fluids
March 6, 2025 - - Latest News -
New report calls for regulatory enforcement and funding to secure nuclear medicine potential
March 6, 2025 - - Latest News -
Organon's Bilal Somra on the welcome and overdue commitment to women’s health
March 6, 2025 - - Latest News -
Sanofi consumer health business secures sustainability certification
March 5, 2025 - - Latest News -
Sepsis survivors at high risk after hospital discharge, new figures reveal
March 5, 2025 - - Other Health -
The George Institute for Global Health welcomes a new board chair
March 5, 2025 - - Australian Biotech -
Atmo Biosciences announces publication of pivotal clinical study results supporting initial indication
March 5, 2025 - - Australian Biotech